Australia’s life sciences sector is growing rapidly, fuelled by pioneering science and the capital needed to take ideas from research to commercialisation.
This October, two flagship AusBiotech events will take place during Australia's biggest week in biotech, connecting innovators with investors and industry leaders: AusBiotech Invest (21 October) and the Early-Stage Innovation Forum (22 October).
Applications for both programs are now open.
AusBiotech Invest: Connecting innovation with capital
Held on 21 October 2025 at Crown Towers, Melbourne, AusBiotech Invest is Australia’s premier life sciences investment conference.
Each year it brings together high-growth companies and global investors, creating an efficient platform to source deals, forge partnerships, and accelerate innovation.
For companies seeking capital, AusBiotech Invest offers the opportunity to pitch breakthrough technologies directly to a concentrated audience of venture capitalists, angel investors, and corporate partners. With up to 30 company presentations, keynote sessions and market intelligence.
For investors, AusBiotech Invest provides exclusive access to high-quality, pre-vetted opportunities across biotechnology, medical technologies, and digital health. Delegates will hear from seasoned investors, assess emerging business models, and explore co-investment opportunities in an environment designed to streamline connections.
Early-Stage Innovation Forum: Spotlighting emerging innovators
The day after Invest, attention turns to Australia’s early-stage ecosystem. The Early-Stage Innovation Forum (ESIF), held on 22 October 2025 at the Melbourne Convention & Exhibition Centre, is the premier forum for research organisations, universities, hospitals, and pre-Series A companies to showcase breakthrough science at the earliest stages of development.
Unlike AusBiotech Invest, which focuses on companies already in the fundraising cycle, ESIF is designed to highlight bold ideas that are still in translation. Successful applicants will pitch in front of an expert panel, with each presentation followed by questions and live feedback. This format not only provides visibility but also equips innovators with constructive insights to refine their commercialisation strategy.
Participants gain sector-wide recognition and increased credibility, with opportunities for exposure through AusBiotech’s publications and networks. For investors and industry leaders, ESIF is a unique window into the pipeline of science and technology that will define the next wave of innovation.
Presenters receive a complimentary day pass to the AusBiotech International Conference on 22 October, with upgrade options available.
Two pathways, one ecosystem
Together, AusBiotech Invest and ESIF reflect the breadth of Australia’s life sciences ecosystem — from research translation to global commercialisation. They are distinct but complementary programs:
- AusBiotech Invest connects companies actively seeking capital with domestic and international investors.
- ESIF gives early-stage innovators a national platform to present their ideas, receive feedback, and build networks for future growth.
Both events are a part of Australia’s biggest week in biotech. They reinforce AusBiotech’s role as the nation’s life sciences peak body, creating connections and enabling knowledge-sharing across the sector. Building an efficient and well-connected investment pipeline is critical to ensuring Australian innovation can thrive globally. By opening doors for companies at every stage of development, AusBiotech Invest and ESIF demonstrate how the sector is advancing breakthroughs in biotechnology, medical technologies, and digital health.
Apply now
Applications are now open for both events:
- AusBiotech Invest (21 October 2025) — Pitching company applications close 7 September. Investors and delegates can apply or register now.
- Early-Stage Innovation Forum (22 October 2025) — Applications close 29 August.
For more details and to apply, visit AusBiotech Invest and Early-Stage Innovation Forum.